Related Experiment Video
Updated: Jul 16, 2026

In Vivo Tracking of Edema Development and Microvascular Pathology in a Model of Experimental Cerebral Malaria Using Magnetic Resonance Imaging
Published on: June 8, 2017
Maculopathy associated with mefloquine (Lariam) therapy for malaria prophylaxis
Randy A Walker1, Kevin M Colleaux
1College of Medicine, University of Saskatchewan, and the Department of Ophthalmology, Saskatoon City Hospital, Canada. ra.walker@shaw.ca
Case Report:
We report maculopathy occurring in a patient after 18 months of weekly mefloquine for malaria prophylaxis. Macular retinal pigment epithelium changes bilaterally were visually insignificant, with the patient demonstrating 20/20 corrected visual acuity bilaterally.
Comments:
Retinal change as an adverse effect of mefloquine has not previously been reported.
Related Concept Videos
Malaria
Rocky Mountain Spotted Fever
Antiprotozoal Agents
Leishmaniasis
Cryptococcal Meningitis

